SLC2A1 and neoplasm: Moreover, while utilizing GLUT1 inhibitors (GLUT1i) to repolarize T-cell-restrictive glyCAF at the tumor margin shows promising results, lineage tracing experiments are necessary to unravel the nature of the glyCAF reprogramming induced by GLUT1 inhibition.